OSRH · XBRL financial data

OSR Health financial statements, every quarter

The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (OSRH's year ends in late December)

In thousands of dollars	Q2 FY23Jun 30, 2023	Q3 FY23Sep 30, 2023	Q4 FY23Feb 14, 2024	Q1 FY24Mar 31, 2024	Q2 FY24Nov 14, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	—	—	—	—	—	915*	761	1,136	628	381*	484	316
Cost of revenue	—	—	—	670	—	755*	593	1,103	366	252*	324	229
Gross profit	—	—	—	240	—	160*	169	33	262	130*	160	87
Research and development	—	—	—	47	—	14*	90	54*	(2)*	177*	113	95*
Selling, general and administrative	280	410	—	451	—	1,773*	3,087	5,262	4,065	6,515*	3,827	3,120
General and administrative	—	—	—	—	—	year only	—	—	—	—	—	—
Operating income (loss)	—	—	—	(3,303)	—	6,555*	(2,918)	(5,229)	(3,803)	(6,386)*	(3,667)	(3,033)
Interest income	—	—	—	6	—	1,439*	4	25	18	17*	17	2
Interest expense	—	—	—	0	—	18*	16	37	44	409*	31	13
Income tax expense (benefit)	229	130	—	90	—	1,409*	—	—	(1,295)	(535)*	(452)	(440)
Net income (loss)	301	78	—	(60)	—	(2,022)*	—	—	—	—	—	—
Earnings per share, basic USD per share	0.03	0.01	—	(0.01)	—	—	(1.04)	0.02	(0.10)	—	(0.09)	(0.02)
Earnings per share, diluted USD per share	0.03	0.01	—	(0.01)	—	—	(1.04)	—	—	—	(0.08)	—
Weighted average shares, basic thousands of shares	9,055	9,055	—	5,623	—	—	10,906	—	—	—	31,213	—
Weighted average shares, diluted thousands of shares	9,055	9,055	—	5,623	—	—	10,906	—	—	—	34,269	—

Balance sheet

CSV

Fiscal quarters (OSRH's year ends in late December)

In thousands of dollars	Q2 FY23Jun 30, 2023	Q3 FY23Sep 30, 2023	Q4 FY23Feb 14, 2024	Q1 FY24Mar 31, 2024	Q2 FY24Nov 14, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	1	58	—	4	—	66	1,596	1,584	2,177	1,700	1,567	1,500
Accounts receivable	—	—	—	—	—	904	795	743	489	319	261	189
Inventory	—	—	—	—	—	922	737	199	185	196	462	594
Total current assets	59	82	—	68	—	455	3,467	2,875	3,204	2,817	2,923	2,866
Property and equipment, net	—	—	—	—	—	2	1	4	98	169	154	142
Right-of-use asset	—	—	—	—	—	78	69	63	50	60	47	35
Goodwill	—	—	—	26,582	—	24,354	24,412	26,394	25,532	24,950	29,729	29,187
Total assets	71,495	72,136	—	37,274	—	2,303	174,550	185,415	177,290	171,238	172,188	166,623
Accrued liabilities	—	—	—	—	—	460	726	907	977	958	1,125	1,089
Current portion of long-term debt	—	—	—	—	—	—	245	631	—	—	197	273
Total current liabilities	541	1,105	—	2,745	—	6,719	13,884	15,856	15,032	17,165	17,898	15,734
Long-term debt	—	—	—	—	—	498	253	—	0	—	273	271
Lease liability, non-current	—	—	—	—	—	33	26	20	12	13	8	4
Total liabilities	2,611	3,175	—	4,815	—	8,789	42,268	46,262	43,132	44,201	44,797	41,715
Accumulated deficit	(2,095)	(2,455)	—	(4,308)	—	(8,334)	(30,566)	(30,175)	(32,328)	(37,170)	(40,101)	(40,950)
Total stockholders' equity	(2,095)	(2,455)	—	(4,308)	—	(8,333)	—	—	—	—	—	—
Total liabilities and equity	71,495	72,136	—	37,274	—	2,303	174,550	185,415	177,290	171,238	172,188	166,623
Common shares outstanding (cover page) thousands of shares	9,055	9,055	5,623	5,623	4,041	19,277	19,277	21,585	25,673	33,125	35,105	35,119

Cash flows

CSV

Fiscal quarters (OSRH's year ends in late December)

In thousands of dollars	Q2 FY23Jun 30, 2023	Q3 FY23Sep 30, 2023	Q4 FY23Feb 14, 2024	Q1 FY24Mar 31, 2024	Q2 FY24Nov 14, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	301	78	—	(60)	—	(2,022)*	—	—	—	—	—	—
Net cash from operating activities	(348)*	(143)*	—	(42)	—	(520)*	(64)	(483)*	(2,711)*	(1,070)*	(1,002)	(2,421)*
Net cash from investing activities	0*	0*	—	(120)	—	35,216*	1,186	(528)*	(727)*	(2,574)*	12	(88)*
Proceeds from issuing common stock	—	—	—	—	—	—	—	—	—	1,411*	845	1,264*
Share repurchases	—	0*	—	—	—	19,186*	—	—	—	—	—	—
Proceeds from long-term debt	—	—	—	122	—	(2)*	—	—	—	—	—	—
Net cash from financing activities	0*	200*	—	150	—	(34,532)*	149	891*	4,116*	3,212*	942	2,473*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
OSR Health	1,500	316	(2,421)*	35.1M	0.6 quarters	Q2 FY26 10-QJun 30, 2026
Sintx Technologies	3,590	452	(2,767)*	6.7M	1.3 quarters	Q2 FY26 10-QJun 30, 2026
Tenon Medical	1,677	1,279	(2,758)*	667,047	0.6 quarters	Q2 FY26 10-QJun 30, 2026
Retractable Technologies	2,641	7,201	(1,732)*	29.9M	1.5 quarters	Q2 FY26 10-QJun 30, 2026
SeaStar Medical Holding	6,959	615	(2,994)*	4.4M	2.3 quarters	Q2 FY26 10-QJun 30, 2026
ENvue Medical	1,084	239	(2,691)*	11.1M	0.4 quarters	Q2 FY26 10-QJun 30, 2026
Bone Biologics	6,088	not reported	(532)*	3.4M	9.8 quarters	Q3 FY26 10-QSep 30, 2026
Adm Tronics Unlimited	223	not reported	(33)	67.6M	6.8 quarters	Q1 FY26 10-QJun 30, 2026
Medinotec	2,584	3,201	108*	11.8M	—	Q2 FY27 10-QAug 31, 2026

Not investment advice. Not affiliated with the U.S. SEC.